General Information of Drug Off-Target (DOT) (ID: OTPH8CZY)

DOT Name MAGUK p55 subfamily member 2 (MPP2)
Synonyms Discs large homolog 2; Protein MPP2
Gene Name MPP2
Related Disease
Attention deficit hyperactivity disorder ( )
Epithelial ovarian cancer ( )
Hepatocellular carcinoma ( )
Lung cancer ( )
Neoplasm ( )
Ovarian cancer ( )
Ovarian neoplasm ( )
Schizophrenia ( )
Tuberous sclerosis ( )
Pituitary tumor ( )
UniProt ID
MPP2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2E7K
Pfam ID
PF00625 ; PF02828 ; PF00595 ; PF07653
Sequence
MPVAATNSETAMQQVLDNLGSLPSATGAAELDLIFLRGIMESPIVRSLAKVIMVLWFMQQ
NVFVPMKYMLKYFGAHERLEETKLEAVRDNNLELVQEILRDLAHVAEQSSTAAELAHILQ
EPHFQSLLETHDSVASKTYETPPPSPGLDPTFSNQPVPPDAVRMVGIRKTAGEHLGVTFR
VEGGELVIARILHGGMVAQQGLLHVGDIIKEVNGQPVGSDPRALQELLRNASGSVILKIL
PSYQEPHLPRQVFVKCHFDYDPARDSLIPCKEAGLRFNAGDLLQIVNQDDANWWQACHVE
GGSAGLIPSQLLEEKRKAFVKRDLELTPNSGTLCGSLSGKKKKRMMYLTTKNAEFDRHEL
LIYEEVARMPPFRRKTLVLIGAQGVGRRSLKNKLIMWDPDRYGTTVPYTSRRPKDSEREG
QGYSFVSRGEMEADVRAGRYLEHGEYEGNLYGTRIDSIRGVVAAGKVCVLDVNPQAVKVL
RTAEFVPYVVFIEAPDFETLRAMNRAALESGISTKQLTEADLRRTVEESSRIQRGYGHYF
DLCLVNSNLERTFRELQTAMEKLRTEPQWVPVSWVY
Function
Postsynaptic MAGUK scaffold protein that links CADM1 cell adhesion molecules to core components of the postsynaptic density. In CA1 pyramidal neurons, required for synaptic KCNN2-containing channel function and long-term potentiation expression. Seems to negatively regulate SRC function in epithelial cells.

Molecular Interaction Atlas (MIA) of This DOT

10 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Attention deficit hyperactivity disorder DISL8MX9 Strong Genetic Variation [1]
Epithelial ovarian cancer DIS56MH2 Strong Altered Expression [2]
Hepatocellular carcinoma DIS0J828 Strong Biomarker [3]
Lung cancer DISCM4YA Strong Altered Expression [4]
Neoplasm DISZKGEW Strong Altered Expression [2]
Ovarian cancer DISZJHAP Strong Altered Expression [2]
Ovarian neoplasm DISEAFTY Strong Altered Expression [2]
Schizophrenia DISSRV2N Strong Biomarker [5]
Tuberous sclerosis DISEMUGZ moderate Biomarker [6]
Pituitary tumor DISN67JD Limited Biomarker [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Cisplatin DMRHGI9 Approved MAGUK p55 subfamily member 2 (MPP2) decreases the response to substance of Cisplatin. [18]
------------------------------------------------------------------------------------
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of MAGUK p55 subfamily member 2 (MPP2). [8]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of MAGUK p55 subfamily member 2 (MPP2). [9]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of MAGUK p55 subfamily member 2 (MPP2). [10]
Temozolomide DMKECZD Approved Temozolomide decreases the expression of MAGUK p55 subfamily member 2 (MPP2). [11]
Testosterone DM7HUNW Approved Testosterone decreases the expression of MAGUK p55 subfamily member 2 (MPP2). [12]
Carbamazepine DMZOLBI Approved Carbamazepine affects the expression of MAGUK p55 subfamily member 2 (MPP2). [8]
Troglitazone DM3VFPD Approved Troglitazone decreases the expression of MAGUK p55 subfamily member 2 (MPP2). [13]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of MAGUK p55 subfamily member 2 (MPP2). [15]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the expression of MAGUK p55 subfamily member 2 (MPP2). [16]
Sulforaphane DMQY3L0 Investigative Sulforaphane decreases the expression of MAGUK p55 subfamily member 2 (MPP2). [17]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the methylation of MAGUK p55 subfamily member 2 (MPP2). [14]
------------------------------------------------------------------------------------

References

1 RasGRP1 promotes amphetamine-induced motor behavior through a Rhes interaction network ("Rhesactome") in the striatum.Sci Signal. 2016 Nov 15;9(454):ra111. doi: 10.1126/scisignal.aaf6670.
2 MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.Cancer Biol Ther. 2019;20(6):897-911. doi: 10.1080/15384047.2019.1579960. Epub 2019 Mar 12.
3 siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells.Biosci Rep. 2015 Mar 18;35(2):e00181. doi: 10.1042/BSR20140145.
4 Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors.Oncogene. 2008 Jul 10;27(30):4137-49. doi: 10.1038/onc.2008.60. Epub 2008 Mar 17.
5 Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia.J Neurosci Res. 2003 Oct 1;74(1):111-22. doi: 10.1002/jnr.10752.
6 Cells derived from tuberous sclerosis show a prolonged S phase of the cell cycle and increased apoptosis.Arch Dermatol Res. 2001 Sep;293(9):460-9. doi: 10.1007/s004030100259.
7 Identification of differentially coexpressed genes in gonadotrope tumors and normal pituitary using bioinformatics methods.Pathol Oncol Res. 2014 Apr;20(2):375-80. doi: 10.1007/s12253-013-9706-1. Epub 2013 Nov 7.
8 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
9 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
10 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
11 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
12 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
13 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
14 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
15 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
16 Bisphenol-A and estradiol exert novel gene regulation in human MCF-7 derived breast cancer cells. Mol Cell Endocrinol. 2004 Jun 30;221(1-2):47-55. doi: 10.1016/j.mce.2004.04.010.
17 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
18 A sensitized RNA interference screen identifies a novel role for the PI3K p110 isoform in medulloblastoma cell proliferation and chemoresistance. Mol Cancer Res. 2011 Jul;9(7):925-35. doi: 10.1158/1541-7786.MCR-10-0200. Epub 2011 Jun 7.